I’ve noticed a recurring trend with many ASX companies I’ve invested in. They often assert that a capital raising isn’t imminent, only to surprise us with an announcement weeks or months later. This tactic is quite common, and IMU is no exception.
I can appreciate your regret over not selling when your shareholdings peaked at $1.1 million. Nonetheless, I believe we’re now witnessing a pivotal moment for the company, especially with its current trials progressing positively. It appears the share price is being deliberately manipulated, and the exorbitant amount of shares on issue isn’t helping.
I firmly believe that IMU has the potential to transform cancer treatment, which could lead to substantial rewards for shareholders and, most importantly, long suffering cancer patients. Good luck.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)